Infant Bacterial Therapeutics AB
IBT-B.ST
#9237
Rank
C$0.10 B
Marketcap
$7.62
Share price
-0.56%
Change (1 day)
-30.94%
Change (1 year)

Infant Bacterial Therapeutics AB (IBT-B.ST) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : C$8.7 Million

According to Infant Bacterial Therapeutics AB's latest financial reports the company's total liabilities are C$8.7 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Infant Bacterial Therapeutics AB - Total liabilities on balance sheet (from 2016 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$9.02 M48.32%
2023-12-31C$6.08 M160.19%
2022-12-31C$2.33 M25.48%
2021-12-31C$1.86 M17.71%
2020-12-31C$1.58 M43.77%
2019-12-31C$1.1 M9.06%
2018-12-31C$1 M-1.29%
2017-12-31C$1.02 M41.52%
2016-12-31C$0.72 M-43.37%
2015-12-31C$1.27 M143.09%
2014-12-31C$0.52 M